108 related articles for article (PubMed ID: 3947145)
1. Comparison of urinary glycosaminoglycan excretion in rheumatoid arthritis, osteoarthritis, myocardial infarction, and controls.
Chuck AJ; Murphy J; Weiss JB; Grennan DM
Ann Rheum Dis; 1986 Feb; 45(2):162-6. PubMed ID: 3947145
[TBL] [Abstract][Full Text] [Related]
2. Urinary glycosaminoglycan excretion in rheumatic diseases.
Kéry V; Orlovská M; Stancíková M; Risko M; Zlnay D
Clin Chem; 1992 Jun; 38(6):841-6. PubMed ID: 1597009
[TBL] [Abstract][Full Text] [Related]
3. Urinary proteoglycan degradation product excretion in patients with rheumatoid arthritis and osteoarthritis.
Krajícková J; Macek J
Ann Rheum Dis; 1988 Jun; 47(6):468-71. PubMed ID: 3382265
[TBL] [Abstract][Full Text] [Related]
4. Relevance of urinary excretion of alcian blue-glycosaminoglycans complexes and hydroxyproline to disease activity in rheumatoid arthritis.
Mbuyi JM; Dequeker J; Teblick M; Merlevede M
J Rheumatol; 1982; 9(4):579-83. PubMed ID: 7131456
[TBL] [Abstract][Full Text] [Related]
5. Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis.
Biçer I; Aksu K; Parildar Z; Tanyalçin T; Doğanavşargil E; Kutay FZ
Rheumatol Int; 2003 Sep; 23(5):221-5. PubMed ID: 14504913
[TBL] [Abstract][Full Text] [Related]
6. Screening study on excretion pattern of urinary glycosaminoglycans from orthopedic patients.
Sato K; Nagatsuka Y; Isemura M; Ototani N; Yosizawa Z
Tohoku J Exp Med; 1982 Jun; 137(2):179-90. PubMed ID: 6810502
[TBL] [Abstract][Full Text] [Related]
7. Excretion pattern of urinary glycosaminoglycans from orthopedic patients.
Nagatsuka Y; Sato K; Satake S; Yosizawa Z
Tohoku J Exp Med; 1981 Apr; 133(4):413-6. PubMed ID: 7256731
[TBL] [Abstract][Full Text] [Related]
8. Assessment of urinary hydroxypyridinium cross-links measurement in osteoarthritis.
Graverand MP; Tron AM; Ichou M; Dallard MC; Richard M; Uebelhart D; Vignon E
Br J Rheumatol; 1996 Nov; 35(11):1091-5. PubMed ID: 8948294
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid, an inhibitor of plasminogen activation, reduces urinary collagen cross-link excretion in both experimental and rheumatoid arthritis.
Ronday HK; Te Koppele JM; Greenwald RA; Moak SA; De Roos JA; Dijkmans BA; Breedveld FC; Verheijen JH
Br J Rheumatol; 1998 Jan; 37(1):34-8. PubMed ID: 9487248
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of free and peptide bound collagen crosslink excretion in different skeletal diseases.
Müller A; Jakob K; Hein GE
Ann Rheum Dis; 2003 Jan; 62(1):65-7. PubMed ID: 12480673
[TBL] [Abstract][Full Text] [Related]
11. [Excretion of proteoglycan degradation products in the urine in patients with rheumatoid arthritis and osteoarthrosis].
Krajícková J; Macek J; Medová N; Adam M
Vnitr Lek; 1987 Feb; 33(2):129-33. PubMed ID: 3824936
[No Abstract] [Full Text] [Related]
12. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis.
Astbury C; Bird HA; McLaren AM; Robins SP
Br J Rheumatol; 1994 Jan; 33(1):11-5. PubMed ID: 8162449
[TBL] [Abstract][Full Text] [Related]
13. Acid glycosaminoglycans in plasma. II. Findings in rheumatoid arthritis.
Friman C; Juvani M; Skrifvars B
Scand J Rheumatol; 1977; 6(3):177-82. PubMed ID: 929124
[TBL] [Abstract][Full Text] [Related]
14. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR
Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
[TBL] [Abstract][Full Text] [Related]
15. Urinary glucaric acid excretion in rheumatoid arthritis: influence of disease activity and disease modifying drugs.
Addyman R; Beyeler C; Astbury C; Bird HA
Ann Rheum Dis; 1996 Jul; 55(7):478-81. PubMed ID: 8774168
[TBL] [Abstract][Full Text] [Related]
16. Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study.
Liu S; Yu Y; Gao Y; Yang X; Pang Z
Urolithiasis; 2016 Apr; 44(2):185-90. PubMed ID: 26242466
[TBL] [Abstract][Full Text] [Related]
17. [Urinary glycosaminoglycans in joint diseases].
Kosiagin DV; Kariakina EK
Revmatologiia (Mosk); 1988; (4):52-6. PubMed ID: 3073501
[No Abstract] [Full Text] [Related]
18. Comparison of urinary excretion of UV-absorbing constituents in healthy subjects and patients with rheumatoid arthritis using analytical isotachophoresis.
Clark PM; Kricka LJ; Whitehead TP
J Chromatogr; 1980 Mar; 181(3-4):347-54. PubMed ID: 7391151
[TBL] [Abstract][Full Text] [Related]
19. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
[TBL] [Abstract][Full Text] [Related]
20. The effects of sulphasalazine on urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis.
Dílek K; Alí I; Göksal K; Hüseyin T; Güner T
Yonsei Med J; 2002 Aug; 43(4):435-40. PubMed ID: 12205730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
